Home/Filings/4/0001387131-22-006577
4//SEC Filing

CARLO DENNIS J PHD 4

Accession 0001387131-22-006577

CIK 0000887247other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:07 PM ET

Size

8.6 KB

Accession

0001387131-22-006577

Insider Transaction Report

Form 4
Period: 2022-05-25
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-05-25250,0000 total
    Common Stock (250,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-05-25+250,000535,867 total
Holdings
  • Common Stock

    (indirect: By Children)
    5,883
  • Common Stock

    (indirect: By Trust)
    150,709
Footnotes (2)
  • [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs.
  • [F2]On March 1, 2017, the reporting person was granted 250,000 Restricted Stock Units. On May 25, 2022 all of these Restricted Stock Units were fully vested.

Documents

1 file

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1
  • filerCIK 0001038322

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:07 PM ET
Size
8.6 KB